Medpace Holdings Is Maintained at Buy by Guggenheim
Medpace Holdings Is Maintained at Buy by Guggenheim
Dow JonesApr 24 13:52 ET
Express News | Guggenheim Maintains Buy on Medpace Hldgs, Raises Price Target to $464
Moomoo 24/7Apr 24 13:43 ET
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2024 Earnings Call Transcript
Yahoo FinanceApr 24 10:37 ET
Medpace Holdings, Inc. Just Beat EPS By 30%: Here's What Analysts Think Will Happen Next
Yahoo FinanceApr 24 08:09 ET
Medpace Holdings Is Maintained at Outperform by Baird
Medpace Holdings Is Maintained at Outperform by Baird
Dow JonesApr 24 07:00 ET
Express News | Medpace Holdings Inc : Guggenheim Raises Target Price to $464 From $453
Moomoo 24/7Apr 24 06:56 ET
Express News | Baird Maintains Outperform on Medpace Hldgs, Raises Price Target to $454
Moomoo 24/7Apr 24 06:50 ET
Medpace Holdings Inc (MEDP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
Yahoo FinanceApr 24 03:08 ET
Q1 2024 Medpace Holdings Inc Earnings Call
Yahoo FinanceApr 23 22:35 ET
ENPH, SEDG and MEDP Are Among After Hour Movers
Seeking AlphaApr 23 17:04 ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $1.7 million. ABVC BioPharma (NAS
BenzingaApr 23 16:31 ET
Earnings Call Summary | Medpace(MEDP.US) Q1 2024 Earnings Conference
The following is a summary of the Medpace Holdings, Inc. (MEDP) Q1 2024 Earnings Call Transcript:Financial Performance:Medpace reported Q1 2024 revenue of $511 million, up by 17.7% year-over-year.The
moomoo AIApr 23 14:56 ET · Conference Call
Express News | Bruker Shares Are Trading Higher Amid Strength in Life Sciences Tools Stocks Following Strong Earnings From Danaher and Strong Guidance From Medpace
Moomoo 24/7Apr 23 13:37 ET
Decoding 5 Analyst Evaluations For Medpace Hldgs
Throughout the last three months, 5 analysts have evaluated Medpace Hldgs (NASDAQ:MEDP), offering a diverse set of opinions from bullish to bearish.The table below summarizes their recent ratings, sho
BenzingaApr 23 12:01 ET
Express News | Medpace Holdings Shares Are Trading Higher After the Company Issued Strong FY24 Guidance. Jefferies Upgraded the Stock to Buy and Raised Its Price Target to $450
Moomoo 24/7Apr 23 11:11 ET
Express News | Jefferies Upgrades Medpace Hldgs to Buy, Raises Price Target to $450
Moomoo 24/7Apr 23 11:08 ET
Medpace Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/23/2024 13.28% Jefferies $340 → $450 Upgrades Hold → Buy 03/18/2024 -0.56% Deutsche Bank → $395 Initiat
BenzingaApr 23 11:06 ET
Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to Research
BusinesswireApr 23 10:40 ET
Are Strong Financial Prospects The Force That Is Driving The Momentum In Medpace Holdings, Inc.'s NASDAQ:MEDP) Stock?
Medpace Holdings (NASDAQ:MEDP) has had a great run on the share market with its stock up by a significant 27% over the last three months. Given that the market rewards strong financials in the long-
Simply Wall StApr 23 10:11 ET
Express News | Medpace Holdings Inc : Jefferies Raises to Buy From Hold; Raises Target Price to $450 From $340
Moomoo 24/7Apr 23 00:11 ET
No Data
No Data